Highlights Strides Pharma Science Limited Bombay S.E.

Equities

STAR

INE939A01011

Delayed Bombay S.E. Other stock markets 05:54:31 26/06/2024 BST			5-day change	1st Jan Change
954.4 ^INR	+1.02%		-0.39%	+47.06%

05-22	Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024
05-22	Strides Pharma Science Limited Announces Chief Financial Officer Changes, Effective June 1, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3%	05-23	MT
Strides Pharma Science Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-22	CI
Market Heavyweights Lifts Indian Equities to End Week Higher	05-10	MT
Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs	04-09	MT
Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-30	CI
Strides Pharma Science Arm Gets US FDA Nod for Pregabalin Capsules	01-26	MT
Strides Pharma Science's Swiss Unit to Sell Entire Stake in Eris Pharma	01-11	MT
Strides Pharma Science Arm Acquires Additional 25% Stake in Neviton Softech	01-08	MT
Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies	01-02	MT
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules	12-01	CI
Strides Pharma Unit Gets US FDA Approval for Generic Bowel Prep Kit Solution	11-23	MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Generic Suprep®? Bowel Prep Kit	11-23	CI
Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	30/10/23	CI
Strides Pharma Science to Sell Singapore Manufacturing Site for $15 Million	30/10/23	MT
Strides Pharma Arm Gets US FDA Nod for HIV Treatment Drug	05/10/23	MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate Tablets	04/10/23	CI
India's Strides Pharma to spin off contract development unit	25/09/23	RE
Strides Pharma Science Arm Gets US FDA Nod for Icosapent Ethyl Capsules	25/09/23	MT
Strides Pharma Global Pte. Limited Receives Tentative United States Food & Drug Administration Approval for Dolutegravir Tablets	14/09/23	CI
Strides Pharma Science Arm Gets US FDA Nod for Sevelamer Carbonate for Oral Suspension	11/09/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Strides Pharma Science Limited Bombay S.E.

Equities

STAR

INE939A01011

Highlights

Filters